| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2164408dacecef4586f14fbce057031a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c6aefbe565f978c6ccbd6d98c39a36e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb5c1d8372afa5bb5f9eaaaed0dc42ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y203-02013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45 |
| filingDate |
2014-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed6a8c1bd60a282350466a26837dc4e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177ad5d523dc2152fa965964ada6f535 |
| publicationDate |
2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015359857-A1 |
| titleOfInvention |
Aerosolized fibrin hemostat |
| abstract |
ClotSpray is a sprayable fibrin-based hemostatic agent applied from an aerosol can. The agent is intended for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and treatment of burns. It can be applied topically to the wound from an aerosol can without need of preparation, unfreezing or interruption during the length of the surgical procedure. Its crosslinking technology generates an adhesive fibrin sealant required for hemostasis. The attachment properties of the gel as well as the instant formation of a fibrin gel ensures that a strong stable fibrin clot will control light to moderate bleeding from a wound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11697128-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022241521-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017223462-A1 |
| priorityDate |
2014-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |